世界のアレルギー性接触皮膚炎(ACDS)市場規模・現状・予測2021-2027

【英語タイトル】Global Allergic Contact Dermatitis (ACDS) Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0241)・商品コード:QY21APR0241
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:98
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、アレルギー性接触皮膚炎(ACDS)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(糖質コルチコイド、局所ステロイド、その他外用剤、コルチコステロイド、抗コリン作用性制吐剤、その他抗不安薬、鎮静剤・催眠剤)、用途別市場規模(局所投与、経口投与)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・アレルギー性接触皮膚炎(ACDS)の市場動向
・企業の競争状況、市場シェア
・アレルギー性接触皮膚炎(ACDS)の種類別市場規模(糖質コルチコイド、局所ステロイド、その他外用剤、コルチコステロイド、抗コリン作用性制吐剤、その他抗不安薬、鎮静剤・催眠剤)
・アレルギー性接触皮膚炎(ACDS)の用途別市場規模(局所投与、経口投与)
・アレルギー性接触皮膚炎(ACDS)の北米市場規模2016-2027(アメリカ、カナダ)
・アレルギー性接触皮膚炎(ACDS)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・アレルギー性接触皮膚炎(ACDS)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・アレルギー性接触皮膚炎(ACDS)の中南米市場規模2016-2027(メキシコ、ブラジル)
・アレルギー性接触皮膚炎(ACDS)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Sandoz、Akorn、Perrigo Company、Taro Pharmaceuticals、Teva Pharmaceuticals、Glenmark Pharmaceuticals)
・結論
【レポートの概要】

Allergic contact dermatitis (ACD) is a common inflammatory skin disorder and an alternative form of contact dermatitis. It is manifestation of allergic responses caused by the contact of an allergic substance such as, nickel, gold, chromium, mercaptobenzothiazole, formaldehyde and many more. The other form of contact dermatitis is irritant contact dermatitis (ICD). Symptoms of allergic contact dermatitis (ACDs) are similar to that of irritant contact dermatitis, which makes the diagnosis harder. The symptoms of allergic contact dermatitis include presence of the skin lesion or rashes at the exposure site. Depending on the allergen type, it may form blisters, papules, simple red spots, vesicles and rashes. The rash can drain, ooze or crust and also becomes raw, thickened or scaled. Allergic contact dermatitis (ACD) is caused as a result of two stages, first stage sensitize and primes the immune system for allergic responses and the second stage, triggers it.   The diagnosis of allergic contact dermatitis includes physical examination and medical therapy. The precise diagnosis based on the symptoms and by rash appearance is very rare. The intermittent or chronic rashes that are not clarified by historical data and physical examination often requires further testing. A patch test (contact delayed hypersensitivity allergy test) is a normally used to detect the actual cause of allergic contact dermatitis.
The global allergic contact dermatitis (ACDS) market is projected to experience rapid growth with increasing prevalence of the diseases and frequently changing lifestyle. The increased focus for the medical treatment of allergic contact dermatitis with perception of providing a comfortable and healthy life, the global allergic contact dermatitis (ACDS) market is anticipated to increase during the forecast period. The key driver of the global allergic contact dermatitis (ACDS) market is the effectiveness of the treatment by reducing the effect of the symptoms. The Increased government concern and improvement in healthcare sectors are some factors facilitating the growth of allergic contact dermatitis (ACDS) market globally. The scarcity of the qualified specialists, equipped amenities, and other skilled professionals for the treatment of allergic contact dermatitis are few factors responsible for restraining the overall growth of the allergic contact dermatitis (ACDS) market.

Market Analysis and Insights: Global Allergic Contact Dermatitis (ACDS) Market
The global Allergic Contact Dermatitis (ACDS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Allergic Contact Dermatitis (ACDS) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Allergic Contact Dermatitis (ACDS) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Allergic Contact Dermatitis (ACDS) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Allergic Contact Dermatitis (ACDS) market.

Global Allergic Contact Dermatitis (ACDS) Scope and Market Size
Allergic Contact Dermatitis (ACDS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Allergic Contact Dermatitis (ACDS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Glucocorticoids
Topical Steroids
Miscellaneous Topical Agents
Corticosteroid
Anticholinergic Antiemetic
Miscellaneous Anxiolytics, Sedatives and Hypnotics

Segment by Application
Topical Administration
Oral Administration

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sandoz
Akorn
Perrigo Company
Taro Pharmaceuticals
Teva Pharmaceuticals
Glenmark Pharmaceuticals

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergic Contact Dermatitis (ACDS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Glucocorticoids
1.2.3 Topical Steroids
1.2.4 Miscellaneous Topical Agents
1.2.5 Corticosteroid
1.2.6 Anticholinergic Antiemetic
1.2.7 Miscellaneous Anxiolytics, Sedatives and Hypnotics
1.3 Market by Application
1.3.1 Global Allergic Contact Dermatitis (ACDS) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Topical Administration
1.3.3 Oral Administration
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Allergic Contact Dermatitis (ACDS) Market Perspective (2016-2027)
2.2 Allergic Contact Dermatitis (ACDS) Growth Trends by Regions
2.2.1 Allergic Contact Dermatitis (ACDS) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Allergic Contact Dermatitis (ACDS) Historic Market Share by Regions (2016-2021)
2.2.3 Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Regions (2022-2027)
2.3 Allergic Contact Dermatitis (ACDS) Industry Dynamic
2.3.1 Allergic Contact Dermatitis (ACDS) Market Trends
2.3.2 Allergic Contact Dermatitis (ACDS) Market Drivers
2.3.3 Allergic Contact Dermatitis (ACDS) Market Challenges
2.3.4 Allergic Contact Dermatitis (ACDS) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Allergic Contact Dermatitis (ACDS) Players by Revenue
3.1.1 Global Top Allergic Contact Dermatitis (ACDS) Players by Revenue (2016-2021)
3.1.2 Global Allergic Contact Dermatitis (ACDS) Revenue Market Share by Players (2016-2021)
3.2 Global Allergic Contact Dermatitis (ACDS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Allergic Contact Dermatitis (ACDS) Revenue
3.4 Global Allergic Contact Dermatitis (ACDS) Market Concentration Ratio
3.4.1 Global Allergic Contact Dermatitis (ACDS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergic Contact Dermatitis (ACDS) Revenue in 2020
3.5 Allergic Contact Dermatitis (ACDS) Key Players Head office and Area Served
3.6 Key Players Allergic Contact Dermatitis (ACDS) Product Solution and Service
3.7 Date of Enter into Allergic Contact Dermatitis (ACDS) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Allergic Contact Dermatitis (ACDS) Breakdown Data by Type
4.1 Global Allergic Contact Dermatitis (ACDS) Historic Market Size by Type (2016-2021)
4.2 Global Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Type (2022-2027)

5 Allergic Contact Dermatitis (ACDS) Breakdown Data by Application
5.1 Global Allergic Contact Dermatitis (ACDS) Historic Market Size by Application (2016-2021)
5.2 Global Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Allergic Contact Dermatitis (ACDS) Market Size (2016-2027)
6.2 North America Allergic Contact Dermatitis (ACDS) Market Size by Type
6.2.1 North America Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021)
6.2.2 North America Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027)
6.2.3 North America Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2027)
6.3 North America Allergic Contact Dermatitis (ACDS) Market Size by Application
6.3.1 North America Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021)
6.3.2 North America Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027)
6.3.3 North America Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2027)
6.4 North America Allergic Contact Dermatitis (ACDS) Market Size by Country
6.4.1 North America Allergic Contact Dermatitis (ACDS) Market Size by Country (2016-2021)
6.4.2 North America Allergic Contact Dermatitis (ACDS) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Allergic Contact Dermatitis (ACDS) Market Size (2016-2027)
7.2 Europe Allergic Contact Dermatitis (ACDS) Market Size by Type
7.2.1 Europe Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021)
7.2.2 Europe Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027)
7.2.3 Europe Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2027)
7.3 Europe Allergic Contact Dermatitis (ACDS) Market Size by Application
7.3.1 Europe Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021)
7.3.2 Europe Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027)
7.3.3 Europe Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2027)
7.4 Europe Allergic Contact Dermatitis (ACDS) Market Size by Country
7.4.1 Europe Allergic Contact Dermatitis (ACDS) Market Size by Country (2016-2021)
7.4.2 Europe Allergic Contact Dermatitis (ACDS) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size (2016-2027)
8.2 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Type
8.2.1 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2027)
8.3 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Application
8.3.1 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2027)
8.4 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Region
8.4.1 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Allergic Contact Dermatitis (ACDS) Market Size (2016-2027)
9.2 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Type
9.2.1 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021)
9.2.2 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027)
9.2.3 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2027)
9.3 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Application
9.3.1 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021)
9.3.2 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027)
9.3.3 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2027)
9.4 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Country
9.4.1 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Country (2016-2021)
9.4.2 Latin America Allergic Contact Dermatitis (ACDS) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size (2016-2027)
10.2 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Type
10.2.1 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2027)
10.3 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Application
10.3.1 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2027)
10.4 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Country
10.4.1 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sandoz
11.1.1 Sandoz Company Details
11.1.2 Sandoz Business Overview
11.1.3 Sandoz Allergic Contact Dermatitis (ACDS) Introduction
11.1.4 Sandoz Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
11.1.5 Sandoz Recent Development
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Akorn Business Overview
11.2.3 Akorn Allergic Contact Dermatitis (ACDS) Introduction
11.2.4 Akorn Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
11.2.5 Akorn Recent Development
11.3 Perrigo Company
11.3.1 Perrigo Company Company Details
11.3.2 Perrigo Company Business Overview
11.3.3 Perrigo Company Allergic Contact Dermatitis (ACDS) Introduction
11.3.4 Perrigo Company Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
11.3.5 Perrigo Company Recent Development
11.4 Taro Pharmaceuticals
11.4.1 Taro Pharmaceuticals Company Details
11.4.2 Taro Pharmaceuticals Business Overview
11.4.3 Taro Pharmaceuticals Allergic Contact Dermatitis (ACDS) Introduction
11.4.4 Taro Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
11.4.5 Taro Pharmaceuticals Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Allergic Contact Dermatitis (ACDS) Introduction
11.5.4 Teva Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Glenmark Pharmaceuticals
11.6.1 Glenmark Pharmaceuticals Company Details
11.6.2 Glenmark Pharmaceuticals Business Overview
11.6.3 Glenmark Pharmaceuticals Allergic Contact Dermatitis (ACDS) Introduction
11.6.4 Glenmark Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
11.6.5 Glenmark Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Allergic Contact Dermatitis (ACDS) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Glucocorticoids
Table 3. Key Players of Topical Steroids
Table 4. Key Players of Miscellaneous Topical Agents
Table 5. Key Players of Corticosteroid
Table 6. Key Players of Anticholinergic Antiemetic
Table 7. Key Players of Miscellaneous Anxiolytics, Sedatives and Hypnotics
Table 8. Global Allergic Contact Dermatitis (ACDS) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Allergic Contact Dermatitis (ACDS) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Allergic Contact Dermatitis (ACDS) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Allergic Contact Dermatitis (ACDS) Market Share by Regions (2016-2021)
Table 12. Global Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Allergic Contact Dermatitis (ACDS) Market Share by Regions (2022-2027)
Table 14. Allergic Contact Dermatitis (ACDS) Market Trends
Table 15. Allergic Contact Dermatitis (ACDS) Market Drivers
Table 16. Allergic Contact Dermatitis (ACDS) Market Challenges
Table 17. Allergic Contact Dermatitis (ACDS) Market Restraints
Table 18. Global Allergic Contact Dermatitis (ACDS) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Allergic Contact Dermatitis (ACDS) Market Share by Players (2016-2021)
Table 20. Global Top Allergic Contact Dermatitis (ACDS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Contact Dermatitis (ACDS) as of 2020)
Table 21. Ranking of Global Top Allergic Contact Dermatitis (ACDS) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Allergic Contact Dermatitis (ACDS) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Allergic Contact Dermatitis (ACDS) Product Solution and Service
Table 25. Date of Enter into Allergic Contact Dermatitis (ACDS) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Allergic Contact Dermatitis (ACDS) Revenue Market Share by Type (2016-2021)
Table 29. Global Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Allergic Contact Dermatitis (ACDS) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Allergic Contact Dermatitis (ACDS) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Allergic Contact Dermatitis (ACDS) Revenue Market Share by Application (2016-2021)
Table 33. Global Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Allergic Contact Dermatitis (ACDS) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Allergic Contact Dermatitis (ACDS) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Allergic Contact Dermatitis (ACDS) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Allergic Contact Dermatitis (ACDS) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Allergic Contact Dermatitis (ACDS) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Allergic Contact Dermatitis (ACDS) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Allergic Contact Dermatitis (ACDS) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Sandoz Company Details
Table 66. Sandoz Business Overview
Table 67. Sandoz Allergic Contact Dermatitis (ACDS) Product
Table 68. Sandoz Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021) & (US$ Million)
Table 69. Sandoz Recent Development
Table 70. Akorn Company Details
Table 71. Akorn Business Overview
Table 72. Akorn Allergic Contact Dermatitis (ACDS) Product
Table 73. Akorn Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021) & (US$ Million)
Table 74. Akorn Recent Development
Table 75. Perrigo Company Company Details
Table 76. Perrigo Company Business Overview
Table 77. Perrigo Company Allergic Contact Dermatitis (ACDS) Product
Table 78. Perrigo Company Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021) & (US$ Million)
Table 79. Perrigo Company Recent Development
Table 80. Taro Pharmaceuticals Company Details
Table 81. Taro Pharmaceuticals Business Overview
Table 82. Taro Pharmaceuticals Allergic Contact Dermatitis (ACDS) Product
Table 83. Taro Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021) & (US$ Million)
Table 84. Taro Pharmaceuticals Recent Development
Table 85. Teva Pharmaceuticals Company Details
Table 86. Teva Pharmaceuticals Business Overview
Table 87. Teva Pharmaceuticals Allergic Contact Dermatitis (ACDS) Product
Table 88. Teva Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021) & (US$ Million)
Table 89. Teva Pharmaceuticals Recent Development
Table 90. Glenmark Pharmaceuticals Company Details
Table 91. Glenmark Pharmaceuticals Business Overview
Table 92. Glenmark Pharmaceuticals Allergic Contact Dermatitis (ACDS) Product
Table 93. Glenmark Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2016-2021) & (US$ Million)
Table 94. Glenmark Pharmaceuticals Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allergic Contact Dermatitis (ACDS) Market Share by Type: 2020 VS 2027
Figure 2. Glucocorticoids Features
Figure 3. Topical Steroids Features
Figure 4. Miscellaneous Topical Agents Features
Figure 5. Corticosteroid Features
Figure 6. Anticholinergic Antiemetic Features
Figure 7. Miscellaneous Anxiolytics, Sedatives and Hypnotics Features
Figure 8. Global Allergic Contact Dermatitis (ACDS) Market Share by Application: 2020 VS 2027
Figure 9. Topical Administration Case Studies
Figure 10. Oral Administration Case Studies
Figure 11. Allergic Contact Dermatitis (ACDS) Report Years Considered
Figure 12. Global Allergic Contact Dermatitis (ACDS) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Allergic Contact Dermatitis (ACDS) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Allergic Contact Dermatitis (ACDS) Market Share by Regions: 2020 VS 2027
Figure 15. Global Allergic Contact Dermatitis (ACDS) Market Share by Regions (2022-2027)
Figure 16. Global Allergic Contact Dermatitis (ACDS) Market Share by Players in 2020
Figure 17. Global Top Allergic Contact Dermatitis (ACDS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Contact Dermatitis (ACDS) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Allergic Contact Dermatitis (ACDS) Revenue in 2020
Figure 19. Global Allergic Contact Dermatitis (ACDS) Revenue Market Share by Type (2016-2021)
Figure 20. Global Allergic Contact Dermatitis (ACDS) Revenue Market Share by Type (2022-2027)
Figure 21. North America Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Allergic Contact Dermatitis (ACDS) Market Share by Type (2016-2027)
Figure 23. North America Allergic Contact Dermatitis (ACDS) Market Share by Application (2016-2027)
Figure 24. North America Allergic Contact Dermatitis (ACDS) Market Share by Country (2016-2027)
Figure 25. United States Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Allergic Contact Dermatitis (ACDS) Market Share by Type (2016-2027)
Figure 29. Europe Allergic Contact Dermatitis (ACDS) Market Share by Application (2016-2027)
Figure 30. Europe Allergic Contact Dermatitis (ACDS) Market Share by Country (2016-2027)
Figure 31. Germany Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Share by Region (2016-2027)
Figure 41. China Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Allergic Contact Dermatitis (ACDS) Market Share by Type (2016-2027)
Figure 49. Latin America Allergic Contact Dermatitis (ACDS) Market Share by Application (2016-2027)
Figure 50. Latin America Allergic Contact Dermatitis (ACDS) Market Share by Country (2016-2027)
Figure 51. Mexico Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Allergic Contact Dermatitis (ACDS) Market Share by Country (2016-2027)
Figure 57. Turkey Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sandoz Revenue Growth Rate in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
Figure 61. Akorn Revenue Growth Rate in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
Figure 62. Perrigo Company Revenue Growth Rate in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
Figure 63. Taro Pharmaceuticals Revenue Growth Rate in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
Figure 64. Teva Pharmaceuticals Revenue Growth Rate in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
Figure 65. Glenmark Pharmaceuticals Revenue Growth Rate in Allergic Contact Dermatitis (ACDS) Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【掲載企業】

Sandoz、Akorn、Perrigo Company、Taro Pharmaceuticals、Teva Pharmaceuticals、Glenmark Pharmaceuticals

★調査レポート[世界のアレルギー性接触皮膚炎(ACDS)市場規模・現状・予測2021-2027] (コード:QY21APR0241)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアレルギー性接触皮膚炎(ACDS)市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆